We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$76.2B
AUM Growth
+$2.6B
Cap. Flow
-$2.97B
Cap. Flow %
-3.9%
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$77.3M
2
BX icon
Blackstone
BX
+$53.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$40.8M
4
PLTR icon
Palantir
PLTR
+$34.3M
5
SNOW icon
Snowflake
SNOW
+$24.8M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$163M
3
LIN icon
Linde
LIN
+$133M
4
AMZN icon
Amazon
AMZN
+$94.7M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$82.6M

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Financials 14.16%
3 Healthcare 12.95%
4 Consumer Discretionary 12.06%
5 Communication Services 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLNX
226
DELISTED
Xilinx Inc
XLNX
$58.8M 0.08%
406,194
-20,617
-5% -$2.62M
ROK icon
227
Rockwell Automation
ROK
$53.5B
$58.7M 0.08%
205,221
-5,002
-2% -$1.35M
AZO icon
228
AutoZone
AZO
$48.8B
$58.6M 0.08%
39,299
-4,340
-10% -$6.29M
IFF icon
229
International Flavors & Fragrances
IFF
$20.6B
$57.9M 0.08%
387,530
-11,874
-3% -$1.7M
ZBH icon
230
Zimmer Biomet
ZBH
$18.8B
$57.8M 0.08%
370,424
-3,884
-1% -$629K
AME icon
231
Ametek
AME
$55.9B
$57.7M 0.08%
432,041
-12,838
-3% -$1.72M
WST icon
232
West Pharmaceutical
WST
$24.5B
$57.4M 0.08%
159,969
-5,176
-3% -$1.71M
TDG icon
233
TransDigm Group
TDG
$71.9B
$57M 0.07%
88,121
-2,691
-3% -$1.69M
KMI icon
234
Kinder Morgan
KMI
$69.9B
$56.8M 0.07%
3,117,808
-146,572
-4% -$2.61M
CTAS icon
235
Cintas
CTAS
$81.6B
$56.7M 0.07%
593,232
-25,480
-4% -$2.26M
MCK icon
236
McKesson
MCK
$96.8B
$56.5M 0.07%
295,637
-27,223
-8% -$5.26M
YUM icon
237
Yum! Brands
YUM
$40.6B
$56.4M 0.07%
490,339
-54,293
-10% -$6.4M
OTIS icon
238
Otis Worldwide
OTIS
$27.5B
$56.4M 0.07%
689,485
-19,532
-3% -$1.5M
PXD
239
DELISTED
Pioneer Natural Resource Co.
PXD
$56.3M 0.07%
346,644
+18,210
+6% +$2.86M
SWKS icon
240
Skyworks Solutions
SWKS
$9.22B
$55.8M 0.07%
291,154
-4,499
-2% -$798K
XEL icon
241
Xcel Energy
XEL
$48.5B
$54M 0.07%
819,850
-55,599
-6% -$3.87M
MXIM
242
DELISTED
Maxim Integrated Products
MXIM
$53.8M 0.07%
511,057
-7,083
-1% -$693K
DOCU
243
DocuSign
DOCU
$10.5B
$53.6M 0.07%
191,723
-3,618
-2% -$809K
LEN icon
244
Lennar Class A
LEN
$20.5B
$53.5M 0.07%
556,658
-19,482
-3% -$1.88M
FAST icon
245
Fastenal
FAST
$55.2B
$53.2M 0.07%
2,047,430
-75,378
-4% -$1.96M
AVB icon
246
AvalonBay Communities
AVB
$27B
$53.1M 0.07%
254,299
-11,474
-4% -$2.29M
HLT icon
247
Hilton Worldwide
HLT
$70.7B
$52.3M 0.07%
433,836
-139
-0% -$17.4K
BBY icon
248
Best Buy
BBY
$18B
$52.3M 0.07%
454,425
-3,749
-0.8% -$438K
RSG icon
249
Republic Services
RSG
$64.5B
$52.2M 0.07%
474,058
-5,138
-1% -$552K
TECH icon
250
Bio-Techne
TECH
$11.2B
$52.1M 0.07%
462,404
-10,768
-2% -$1.13M

Similar funds

RhumbLine Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.

  • RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
  • RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
  • RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
  • RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
  • RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
  • RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.